B-cell Lymphoma

Showing 1 - 25 of 71

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Normal Subjects and Disorders of Immune System and Cancer

Recruiting
  • T-cell Lymphoma
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    B Cell ALL, B-Cell Lymphoma, B-cell Non Hodgkin Lymphoma Trial in Hackensack, New York (Anakinra)

    Recruiting
    • B Cell ALL
    • +2 more
    • Hackensack, New Jersey
    • +1 more
    Aug 22, 2022

    Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

    Recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +6 more
    • San Francisco, California
    • +18 more
    Aug 16, 2022

    B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

    Recruiting
    • B-Cell Lymphoma
    • +8 more
    • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
    • Pittsburgh, Pennsylvania
      AHN Cancer Institute - West Penn Hospital
    Aug 10, 2022

    r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

    Not yet recruiting
    • B-cell Lymphoma
    • Beijing, Beijing, China
      Deparment of Hematology, Peking University People's Hospital
    Aug 9, 2022

    NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

    Not yet recruiting
    • NHL, Relapsed, Adult
    • +3 more
    • KUR-502
    • (no location specified)
    Aug 2, 2022

    Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

    Recruiting
    • Follicular Lymphoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 20, 2022

    B-cell Lymphoma, Burkitt Lymphoma Trial in Milwaukee (Etoposide, Doxorubicin, Cyclophosphamide)

    Not yet recruiting
    • B-cell Lymphoma
    • Burkitt Lymphoma
    • Milwaukee, Wisconsin
      Froedtert Hospital & the Medical College of Wisconsin
    Jun 11, 2022

    B-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Hangzhou (QN-019a, Rituximab, Cyclophosphamid)

    Recruiting
    • B-cell Lymphoma
    • B-cell Acute Lymphoblastic Leukemia
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical College of Zhejiang Uni
    May 17, 2022

    B-Cell Lymphoma, MDS (MDS), Acute Myeloid Leukemia (AML) Trial in Houston (Cyclophosphamide, CAR.70/IL15-transduced CB-NK cells,

    Not yet recruiting
    • B-Cell Lymphoma
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 12, 2022

    B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

    Not yet recruiting
    • B-cell Non-Hodgkin Lymphoma
    • +4 more
    • (no location specified)
    May 6, 2022

    B-cell Lymphoma Trial in Sanhe (CD19/CD20 Dual-CAR-T cells)

    Completed
    • B-cell Lymphoma
    • CD19/CD20 Dual-CAR-T cells
    • Sanhe, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Mar 6, 2022

    B-cell Lymphoma Trial in Beijing, Guangzhou (LP-168 tablet)

    Recruiting
    • B-cell Lymphoma
    • LP-168 tablet
    • Beijing, Beijing, China
    • +2 more
    Feb 24, 2022

    B-cell Lymphoma Trial in Israel, Puerto Rico, Turkey (ABBV-623, ABBV-992)

    Active, not recruiting
    • B-cell Lymphoma
    • Ramat Gan, Tel-Aviv, Israel
    • +4 more
    Feb 7, 2022

    B-cell Lymphoma Trial in Belgium, France (selinexor, Rituximab, Dexamethasone)

    Completed
    • B-cell Lymphoma
    • Bruxelles, Belgium
    • +7 more
    Dec 6, 2021

    B-cell Lymphoma Trial in Randwick, Clayton, Fitzroy (Glofitamab, Gemcitabine, Oxaliplatin)

    Completed
    • B-cell Lymphoma
    • Randwick, New South Wales, Australia
    • +2 more
    Nov 23, 2021

    B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

    Recruiting
    • B-cell Lymphoma
    • +8 more
    • Polatuzumab vedotin
    • Valhalla, New York
      New York Medical Center
    Oct 29, 2021

    B-cell Lymphoma Trial in China (Zanubrutinib)

    Completed
    • B-cell Lymphoma
    • Beijing, Beijing, China
    • +3 more
    Sep 26, 2021

    B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL Trial in Boston (Venetoclax, Dexamethasone, Inotuzumab Ozogamicin)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 19, 2021

    B-cell Lymphoma Trial (Orelabrutinib tablet, Lenalidomide)

    Not yet recruiting
    • B-cell Lymphoma
    • (no location specified)
    Aug 23, 2021

    B-cell Lymphoma Trial in Kunming (CTA30X UCAR-T injection)

    Recruiting
    • B-cell Lymphoma
    • CTA30X UCAR-T injection
    • Kunming, Yunnan, China
      No.212 Daguan Road, Xishan District
    Aug 15, 2021

    Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma

    Withdrawn
    • B-cell Lymphoma
    • Covid19
      • (no location specified)
      Aug 13, 2021

      B-Cell Leukemia, B-Cell Lymphoma Trial in Guangzhou (4SCAR19/22 T cells, Interleukin-2)

      Suspended
      • B-Cell Leukemia
      • B-Cell Lymphoma
      • Guangzhou, Guangdong, China
        Zhujiang Hospital of Southern Medical University
      Aug 9, 2021